Nuclear Medicine Content
Geriatrics and Palliative Medicine 2023 Specialty Report
The Mount Sinai Hospital is ranked No. 1 in Geriatrics in the nation by U.S. News & World Report for the third consecutive year.
Urology Training Program at Mount Sinai Offers Residents Unique Opportunities
The Urology Residency Program of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai provides residents the opportunity to train in all aspects of the medical and surgical evaluation and treatment ...
Mount Sinai’s Department of Urology continues to make strides in training a new generation in the necessary clinical, surgical, and decision-making skills to deliver outstanding care to patients in an area undergoing rapid change.
Advancing the Field of Sex Reassignment Surgery Through Innovative Approaches
Mount Sinai has established itself as a leader in sex reassignment surgery (SRS) and reconstruction of genitalia, thanks in part to the pioneering work of Miroslav Djordjevic, MD, PhD, a leading authority on surgery for transgender individuals.
Prostate Cancer Program: Two Pioneering Studies
For more than a decade, Ash Tewari, MBBS, MCh, FRCS (Hon.), has been a leader in advancing the safety and precision of robot-assisted radical prostatectomies.
By continuing to perfect the miniaturization of percutaneous nephrolithotomy (PCNL), surgeons at the Mount Sinai Department of Urology are significantly improving outcomes for patients with larger kidney stones.
Kidney Research Pipeline to Enhance Precision in Surgical Intervention Decisions
Advances in imaging, biomarkers, and genetic testing continue to benefit patients who present with prostate and bladder cancers.
Two Physician-Researchers Making Unique Contributions to Urology Innovation
Two physician-researchers in the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai have been recognized for making unique contributions to urology research...
Mount Sinai has developed a protocol that eliminates opioids from postoperative pain management with exceptional results.
Harnessing Immunotherapy to Achieve Improved Outcomes for Patients With Prostate Cancer
Although there is considerable interest in using immunotherapy to combat and control prostate cancer, there has been little progress made in harnessing the potential of this approach.
Better Diagnosis Holds the Key to Improved Outcomes for BPH Patients
As the family of technologies for treating benign prostatic hyperplasia (BPH) continues to grow, the key to successful outcomes for male patients may well rest on a rather simple tenet: better diagnostic acumen.
Organoids Enable Pathophysiology, Treatment Studies of Rare Renal Cell Carcinomas
For years, rare renal cell carcinomas (RCCs), such as papillary RCC, have been understudied because their incidences are too low to support clinical trials.
An innovative effort by the Milton and Carroll Petrie Department of Urology and Ash Tewari, MBBS, MCh, FRCS (Hon.), Professor and System Chair, to improve early detection of prostate cancer among at-risk populations in New York City...
Mount Sinai's New Lung Transplantation Program Takes on Complex Cases
Mount Sinai’s Scott Scheinin, MD, and Harish Seethamraju, MD, are establishing the End-Stage Lung Disease and Transplant Program as a leader in treating complex cases.
Brief Withdrawal of Apnea Therapy Could Increase Alzheimer's Risk
A first-of-its-kind study led by a Mount Sinai researcher suggests that even a brief withdrawal of continuous positive airway pressure therapy for sleep apnea might increase one’s risk of developing Alzheimer’s disease.